BIOMAT Database Logo BIOMAT Database Logo

Endocrine adjuvant therapy for breast cancer. 1985

A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli

UI MeSH Term Description Entries
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Adjuvant endocrine therapy for breast cancer.
June 2012, Oncology (Williston Park, N.Y.),
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
[Adjuvant endocrine therapy for breast cancer].
April 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Breast cancer adjuvant endocrine therapy.
January 2007, Cancer journal (Sudbury, Mass.),
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Adjuvant endocrine therapy for operable breast cancer.
January 1991, Bulletin du cancer,
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Optimal adjuvant endocrine therapy for breast cancer.
October 2021, The Lancet. Oncology,
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Endocrine Adjuvant Therapy for Localized Breast Cancer.
July 2018, The New England journal of medicine,
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
[Adjuvant for breast cancer chemo-endocrine therapy].
March 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Adjuvant endocrine therapy for early breast cancer.
June 2007, Cancer letters,
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Selecting adjuvant endocrine therapy for breast cancer.
December 2004, Oncology (Williston Park, N.Y.),
A Goldhirsch, and R D Gelber, and M N Tattersall, and C M Rudenstam, and F Cavalli
Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
October 2018, The New England journal of medicine,
Copied contents to your clipboard!